IFP Advisors’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$146 Sell
38
-55
-59% -$225 ﹤0.01% 4676
2025
Q4
$345 Buy
93
+62
+200% +$532 ﹤0.01% 4369
2025
Q3
$438 Buy
31
+30
+3,000% +$468 ﹤0.01% 4210
2025
Q2
$19 Sell
1
-16
-94% -$250 ﹤0.01% 4849
2025
Q1
$20 Buy
17
+15
+750% +$179 ﹤0.01% 4168
2024
Q4
$38 Hold
2
﹤0.01% 4327
2024
Q3
$23 Hold
2
﹤0.01% 3269
2024
Q2
$131 Sell
2
-129
-98% -$6.32K ﹤0.01% 3157
2024
Q1
$4.35K Sell
131
-1
-0.8% -$51 ﹤0.01% 2496
2023
Q4
$10.7K Buy
132
+1
+0.8% +$81 ﹤0.01% 2165
2023
Q3
$21.3K Hold
131
﹤0.01% 1917
2023
Q2
$43.1K Sell
131
-2
-2% -$610 ﹤0.01% 1672
2023
Q1
$121K Sell
133
-1
-0.7% -$367 0.01% 1159
2022
Q4
$121K Hold
134
﹤0.01% 1642
2022
Q3
$122K Buy
134
+1
+0.8% +$268 ﹤0.01% 1716
2022
Q2
$121K Hold
133
﹤0.01% 1565
2022
Q1
$121K Buy
133
+15
+13% +$9.03K ﹤0.01% 1565
2021
Q4
$82K Buy
+118
New +$87.3K ﹤0.01% 1349

Other funds holding OM

IFP Advisors's OM Position: Q1 2026 in Review

IFP Advisors reduced its Outset Medical (OM) stake by 59% in Q1 2026, selling an estimated $225 and leaving 38 shares worth $146. The position accounts for ﹤0.01% of the portfolio, ranked #4676.

IFP Advisors first reported a position in OM in Q4 2021 and has held it in 18 quarters since. The position peaked at $122K in Q3 2022. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • IFP Advisors held 38 shares of Outset Medical worth $146 as of Q1 2026.
  • IFP Advisors sold 55 Outset Medical shares in Q1 2026, an estimated $225.
  • Outset Medical made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #4676 holding.
  • IFP Advisors first reported a position in Outset Medical in Q4 2021 and has held it in 18 quarters since.
  • IFP Advisors's Outset Medical position peaked at $122K in Q3 2022.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.